Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials
As a 2026 review noted, the original composition-of-matter patents "have likely expired reducing the commercial exclusivity that typically incentivizes industry-sponsored Phase II and III development" [13]
Pigment Cell Res
Quality, dose, formulation, and sourcing can vary significantly, and compounded versions are not subject to the same regulatory oversight as approved drugs
For those looking to enhance recovery, reduce inflammation, and support gut health, BPC-157 peptide has gained attention as a promising therapeutic compound
In one, patients who lost 10.6% of their weight after 20 weeks of Wegovy were randomized to continue it or switch to placebo